⚠️ Arkansas statute of limitations: 3 years. If you experienced GLP-1 related side effects consult a legal professional about your specific deadline immediately.
Can Arkansas Residents File GLP-1 Lawsuits?
Yes. Arkansas residents who took GLP-1 medications including Ozempic, Wegovy, Mounjaro, Zepbound, or compounded semaglutide and suffered documented side effects are eligible to have their cases reviewed. Arkansas has a 3-year statute of limitations for product liability claims giving residents more time than most states. Arkansas has high rates of obesity and diabetes making it one of the states with significant GLP-1 medication use per capita. All cases are filed in federal court as part of the Multi-District Litigation regardless of what state you live in.
Active Lawsuit Conditions for Arkansas Residents
- Gastroparesis or stomach paralysis requiring medical treatment or hospitalization — learn more about gastroparesis lawsuits
- NAION or sudden vision loss diagnosed by a physician — learn more about vision loss lawsuits
- Severe pancreatitis requiring hospitalization — learn more about pancreatitis lawsuits
- Gallbladder disease or emergency gallbladder removal — learn more about gallbladder lawsuits
- Intestinal blockage or obstruction requiring treatment
- Any serious documented medical condition occurring during or after GLP-1 medication use
Where Do These Cases Stand in May 2026?
As of May 2026 over 12,000 cases have been filed in federal multidistrict litigation across two separate MDLs — one for gastrointestinal injuries and one specifically for vision loss. A Science Day has been scheduled for June 2, 2026 where both sides will present evidence on the NAION vision loss claims. Bellwether trial selection is expected in late 2026. This is an active and rapidly developing litigation — Arkansas residents who submit their cases now are in the best position for early settlement discussions.
For full details on current case developments see our monthly litigation timeline.
Which Medications Are Involved?
- Ozempic (semaglutide injection) — Novo Nordisk
- Wegovy (semaglutide injection) — Novo Nordisk
- Rybelsus (oral semaglutide) — Novo Nordisk
- Mounjaro (tirzepatide) — Eli Lilly
- Zepbound (tirzepatide) — Eli Lilly
- Compounded semaglutide from any online telehealth platform
How Much Could a Case Be Worth?
No formal settlement amounts have been established yet in GLP-1 litigation. Case value depends on the severity and permanence of the injury, quality of medical documentation, whether a formal diagnosis was made, and whether you experienced lost income or ongoing treatment costs. Permanent injuries such as vision loss or chronic gastroparesis carry higher values than resolved conditions. Learn more on our settlement value page.
Does It Cost Anything to File?
No. Attorneys in our network work on contingency — meaning they only get paid when you receive compensation. There is no upfront cost, no retainer, and no fee if you receive nothing. The case review is completely free and takes approximately 5 to 10 minutes. A legal case specialist will contact you within 24 hours of submitting your information.
What Documentation Helps Your Case?
- Prescription records or telehealth consultation records showing GLP-1 use and dates
- Pharmacy receipts or medication packaging
- Emergency room or hospital records from treatment related to your symptoms
- Any specialist diagnosis documents related to your condition
- Records of lost income or ongoing medical treatment costs
- Photographs of medication packaging if available
📋 Even if you do not currently have these documents a legal team can help you obtain them through the discovery process. Not having paperwork on hand does not disqualify you from having your case reviewed.
Check Your Eligibility — Free
90 seconds. No cost. No obligation. Completely confidential.